Rheumatoid Arthritis Refractory to DMARDs: A Case Study

Authors: Sakhawat F and Sadeeqa S

DOI: 10.23880/vij-16000163

Volume 2, Issue 5

Abstract

In past few years there has been an enthusiastic progress in the field of rheumatoid arthritis pharmacotherapy but the presence of prognostic factors associated with unfavorable outcomes and the inappropriate and/or delayed initiation of DMARDsmay diminish the likelihood of achieving remission and/or increase the probability of refractoriness to treatment.

Keywords: Rheumatoid arthritis; Unfavorable outcomes; Refractory patients; DMARDs; Biologics

View PDF